The Indian pharmaceutical industry operates under the Drugs and Cosmetics Act, 1940, and its subsequent rules. This legislation governs manufacturing, quality control, and distribution. The Central Drugs Standard Control Organization (CDSCO) is the primary regulatory body, ensuring adherence to Good Manufacturing Practices (GMP) guidelines. These GMP guidelines are based on international standards, aiming for consistent product quality and safety.
Manufacturing Approvals and Inspections
Companies seeking to manufacture drugs must obtain licenses from the CDSCO. This involves rigorous facility inspections and thorough review of manufacturing processes. Regular inspections continue throughout operation. The CDSCO also reviews the safety and efficacy data supporting new drug applications before market authorization. These processes help to ensure that medications meet minimum quality and safety benchmarks.
Post-Market Surveillance
Post-market surveillance monitors drug safety after they reach consumers. The CDSCO actively investigates adverse drug reactions (ADRs) and issues safety alerts when necessary. This continuous monitoring helps identify potential problems and enables timely corrective actions. The system is designed to react quickly to emerging safety concerns.
Import and Export Regulations
Importing and exporting pharmaceuticals requires complying with specific regulations. Appropriate licenses and certifications are needed, and products must meet both Indian and exporting country standards. These regulations prevent the entry of substandard or counterfeit medications and ensure international trading practices align with safety regulations.
